BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 30609136)

  • 1. Homeodomain interacting protein kinase-2 phosphorylates FOXM1 and promotes FOXM1-mediated tumor growth in renal cell carcinoma.
    Liu F; Li N; Liu Y; Zhang J; Zhang J; Wang Z
    J Cell Biochem; 2019 Jun; 120(6):10391-10401. PubMed ID: 30609136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-132 suppresses migration and invasion of renal carcinoma cells.
    Yu Y; Lu W; Zhou X; Huang H; Shen S; Guo L
    J Clin Lab Anal; 2020 Jan; 34(1):e22969. PubMed ID: 31625200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLK1 and FoxM1 expressions positively correlate in papillary thyroid carcinoma and their combined inhibition results in synergistic anti-tumor effects.
    Poyil PK; Siraj AK; Padmaja D; Parvathareddy SK; Thangavel S; Alobaisi K; Diaz R; Begum R; Haqawi W; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Mol Oncol; 2024 Mar; 18(3):691-706. PubMed ID: 38361222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase.
    Wang IC; Chen YJ; Hughes D; Petrovic V; Major ML; Park HJ; Tan Y; Ackerson T; Costa RH
    Mol Cell Biol; 2005 Dec; 25(24):10875-94. PubMed ID: 16314512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidation of WW domain ligand binding specificities in the Hippo pathway reveals STXBP4 as YAP inhibitor.
    Vargas RE; Duong VT; Han H; Ta AP; Chen Y; Zhao S; Yang B; Seo G; Chuc K; Oh S; El Ali A; Razorenova OV; Chen J; Luo R; Li X; Wang W
    EMBO J; 2020 Jan; 39(1):e102406. PubMed ID: 31782549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let-7d inhibits intratumoral macrophage M2 polarization and subsequent tumor angiogenesis by targeting IL-13 and IL-10.
    Su B; Han H; Gong Y; Li X; Ji C; Yao J; Yang J; Hu W; Zhao W; Li J; Zhang G; Zhou L
    Cancer Immunol Immunother; 2021 Jun; 70(6):1619-1634. PubMed ID: 33237349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 is a therapeutic target for high-risk multiple myeloma.
    Gu C; Yang Y; Sompallae R; Xu H; Tompkins VS; Holman C; Hose D; Goldschmidt H; Tricot G; Zhan F; Janz S
    Leukemia; 2016 Apr; 30(4):873-82. PubMed ID: 26648534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the master regulator FOXM1 in cancer.
    Liao GB; Li XZ; Zeng S; Liu C; Yang SM; Yang L; Hu CJ; Bai JY
    Cell Commun Signal; 2018 Sep; 16(1):57. PubMed ID: 30208972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead Box Protein M1 (FOXM1): Prospective Prognostic Biomarker and Therapeutic Targets in Oral Cancer.
    Venkidasamy B; Samynathan R; Govidasamy R
    Curr Cancer Drug Targets; 2023; 23(11):834-836. PubMed ID: 37259930
    [No Abstract]   [Full Text] [Related]  

  • 10. TRIM65 promotes renal cell carcinoma through ubiquitination and degradation of BTG3.
    Zhang Q; Li Y; Zhu Q; Xie T; Xiao Y; Zhang F; Li N; Deng K; Xin H; Huang X
    Cell Death Dis; 2024 May; 15(5):355. PubMed ID: 38777825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer.
    Zhao Z; Cai Z; Zhang S; Yin X; Jiang T; Shen C; Yin Y; Sun H; Chen Z; Han J; Zhang B
    Cancer Lett; 2024 May; 589():216796. PubMed ID: 38537775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. POLE2 facilitates the malignant phenotypes of glioblastoma through promoting AURKA-mediated stabilization of FOXM1.
    Zhang P; Chen X; Zhang L; Cao D; Chen Y; Guo Z; Chen J
    Cell Death Dis; 2022 Jan; 13(1):61. PubMed ID: 35039475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor FOXM1 specifies chromatin DNA to extracellular vesicles.
    Zhang Y; Ding N; Li Y; Ouyang M; Fu P; Peng Y; Tan Y
    Autophagy; 2024 May; 20(5):1054-1071. PubMed ID: 37974331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes as potential biomarkers in renal cell carcinoma.
    Hage Chehade C; Agarwal N
    Cancer Cell; 2024 May; 42(5):736-738. PubMed ID: 38670092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular subtypes and prognosis in RCC.
    Beuselinck B; Fridman WH; Zucman-Rossi J
    Aging (Albany NY); 2015 Apr; 7(4):219-20. PubMed ID: 25885644
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelial FoxM1 reactivates aging-impaired endothelial regeneration for vascular repair and resolution of inflammatory lung injury.
    Huang X; Zhang X; Machireddy N; Evans CE; Trewartha SD; Hu G; Fang Y; Mutlu GM; Wu D; Zhao YY
    Sci Transl Med; 2023 Aug; 15(709):eabm5755. PubMed ID: 37585502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retraction Note: FoxM1-mediated RFC5 expression promotes temozolomide resistance.
    Peng WX; Han X; Zhang CL; Ge L; Du FY; Jin J; Gong AH
    Cell Biol Toxicol; 2024 Jun; 40(1):43. PubMed ID: 38850404
    [No Abstract]   [Full Text] [Related]  

  • 18. A new role for Drosophila Aurora-A in maintaining chromosome integrity.
    Merigliano C; Mascolo E; Cesta A; Saggio I; Vernì F
    Chromosoma; 2019 Mar; 128(1):41-52. PubMed ID: 30612150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXM1-regulated ZIC2 promotes the malignant phenotype of renal clear cell carcinoma by activating UBE2C/mTOR signaling pathway.
    Lv Z; Wang M; Hou H; Tang G; Xu H; Wang X; Li Y; Wang J; Liu M
    Int J Biol Sci; 2023; 19(11):3293-3306. PubMed ID: 37496990
    [No Abstract]   [Full Text] [Related]  

  • 20. A comprehensive analysis of the FOX family for predicting kidney renal clear cell carcinoma prognosis and the oncogenic role of FOXG1.
    Yang W; Chen H; Ma L; Dong J; Wei M; Xue X; Li Y; Jin Z; Xu W; Ji Z
    Aging (Albany NY); 2022 Dec; 14(24):10107-10124. PubMed ID: 36585925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.